✦ LIBER ✦

Treatment of minimal residual disease in poor risk acute lymphoblastic leukaemia with high-dose cytosine arabinoside (ARA-C)

✍ Scribed by M.J. Barnett; J.E. Kingston; A. Miller; L.K. Goff; T.S. Ganesan; R. Biruls; A.Z.S. Rohatiner; J.S. Malpas; T.A. Lister

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose (HD) cytosine arabinoside (ARA

✍ G.P. Herzig; S.N. Wolff; R.H. Herzig; R.S. Stein; H.M. Lazarus; J.M. Marion; T.R 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The use of intermediate dose cytosine ar

✍ H. C. van Prooijen; A. W. Dekker; K. Punt 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Immunological detection of minimal resid

✍ Elaine Coustan-Smith; Frederick G Behm; Joaquin Sanchez; James M Boyett; Michael 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 74 KB

Results of induction and consolidation t

✍ W. G. Peters; R. Willemze; L. P. Colly 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Limited efficacy of a four-day course of

✍ Harvey D. Preisler; Azra Raza; Richard Larson; George Browman; Jack Goldberg; Ha 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 351 KB

Molecular detection of minimal residual

✍ Foroni, L; Coyle, L A; Papaioannou, M; Yaxley, J C; Sinclair, MF Cole; Chim, J S 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 556 KB